Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05286008Unknown
Randomised, double-blind trial of ropivacaine in postoperative nausea and vomiting (PONV) and postoperative pain (3 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: Postoperative nausea and vomiting. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05286008.